BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine

Overview of attention for article published in Frontiers in oncology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 23,814 followers.

#4 Original Research Article: BTG2 suppresses #renalcellcarcinoma progression through N6-methyladenosine 👨‍⚕️👩‍⚕️ Qi F et al 👉 https://t.co/fMdUrxIqmX #UroOnc #RNA

16 Dec 2022

Reply Repost Favourite

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine https://t.co/dEAkONyssb https://t.co/OJYb4q1qqr

15 Dec 2022

Reply Repost Favourite

New research: BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine: The biological functions of N6-methyladenosine (m6A) modification of mRNA have recently received a great deal of attention. In previous studies, m6A… https://t.co/zo

15 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.